HAVE OUR BACKS
×
Sign Up
Already Registered?
face
lock_outline
THE FACTS
BIO
BIO
VOTES
VOTES
POSITIONS
POSITIONS
RATINGS
RATINGS
SPEECHES
SPEECHES
FUNDING
FUNDING
Please have our backs
No Thank You
John Dingell's Public Statements on Issue: Drugs
Deceased
Track This Politician
Current Issue:
Drugs
Select Issue
All
Abortion
Agriculture and Food
Animals and Wildlife
Arts, Entertainment, and History
Business and Consumers
Campaign Finance
Civil Liberties and Civil Rights
Constitution
Criminal Justice
Death Penalty
Defense
Drugs
Economy and Fiscal
Education
Elections
Employment and Affirmative Action
Energy
Entitlements and the Safety Net
Environment
Executive Branch
Family
Federal, State and Local Relations
Finance and Banking
Food Processing and Sales
Foreign Affairs
Foreign Aid
Gambling and Gaming
Government Budget and Spending
Government Operations
Guns
Health Insurance
Health and Health Care
Higher Education
Housing and Property
Immigration
Indigenous Peoples
Infrastructure
Judicial Branch
K-12 Education
Labor Unions
Legal
Legislative Branch
Marijuana
Marriage
Military Personnel
Minors and Children
Monetary Policy
National Security
Natural Resources
Oil and Gas
Religion
Reproduction
Science
Senior Citizens
Sexual Orientation and Gender Identity
Stem Cell Research
Taxes
Technology and Communication
Trade
Transportation
Unemployed and Low-Income
Veterans
Women
Speech Type
Select Speech Type
All
Debate
Executive Order
Floor Speech
Hearing
Interview
Issue Position
Letter
News Article
Op-Ed
Other
Pledge
Press Conference
Press Release
Social Media
Speech
Statement
Date Range
Start Date
End Date
Apply
Keyword Search
close
Reset Search
attach_money
Who is funding Dingell?
Page 1 of 3
1
2
3
chevron_right
Date
Title
05/07/2013
Dingell Statement on Prescription Drug "Track & Trace" Markup
06/20/2012
Food and Drug Administration Safety and Innovation Act
06/12/2012
Dingell, UM Professor Dr. Johnston To Discuss $7M Grants from HHS
05/30/2012
User Fee Bill Co-Authored by Dingell Passes House
01/01/2012
Issue Position: Food & Drug Protection
07/07/2011
Dingell: FDA Confirms Authorities and Funding Included in H.R. 1483 Will Help to Prevent Another Heparin-Like Event
06/16/2011
House Democratic Leaders Introduce Legislation to Save More than $100 Billion in Medicare Drug Costs
06/16/2011
House Democratic Leaders Introduce Legislation to Save More Than $100 Billion in Medicare Drug Costs
06/15/2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012
04/12/2011
Dingell, Waxman, Pallone, & DeGette Introduce Drug Safety Enhancement Act
12/21/2010
FDA Food Safety Modernization Act
12/17/2010
Dingell, Waxman, Pallone, & Stupak Introduce Drug Safety Legislation
12/08/2010
Full-year Continuing Appropriations Act, 2011
09/20/2010
Waxman, Dingell, Pallone & Stupak Open Discussion on Potentially Historic Changes in Drug Safety Laws
08/27/2010
Statement on GAO'S Clinical Trials Report
05/27/2010
Dingell Stresses Need For Additional Drug Safety Authorities
07/30/2009
Providing for Consideration of H.R. 2749, Food Safety Enhancement Act of 2009
06/23/2009
Panel II Of A Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Comprehensive Health Reform
06/12/2009
Dingell Praises Family Smoking Prevention And Tobacco Control Act.'
06/11/2009
Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition
05/01/2009
Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - The 2009 H1N1 Flu Outbreak And The United States Federal Response
07/17/2008
Dingell, Stupak Question Whether FDA Knowingly Allowed Potentially Unsafe & Ineffective Drugs into the U.S. Marketplace
05/01/2008
Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation
04/30/2008
Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Heparin Disaster: Chinese Counterfeits and American Failures
04/22/2008
Panel I of a Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Food and Drug Administration's Foreign Drug Inspection Program
Page 1 of 3
1
2
3
chevron_right
attach_money
Who is funding Dingell?
clear
Log in
face
lock_outline
face
person
person_outline
email
lock
lock_outline
Enter the same password as above, for verification.
arrow_upward